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a b s t r a c t
Adenovirus-mediated apoptosis was suppressed when cellular anti-apoptosis proteins (BCL-2 and BCL-
xL) were substituted for the viral E1B-19K. For unbiased proteomic analysis of proteins targeted by BCL-
xL in adenovirus-infected cells and to visualize the interactions with target proteins, BCL-xL was targeted
to cytosolic inclusion bodies utilizing the orthoreovirus mNS protein sequences. The chimeric protein was
localized in non-canonical cytosolic factory-like sites and promoted survival of virus-infected cells. The
BCL-xL-associated proteins were isolated from the cytosolic inclusion bodies in adenovirus-infected cells
and analyzed by LC–MS. These proteins included BAX, BAK, BID, BIK and BIM as well as mitochondrial
proteins such as prohibitin 2, ATP synthase and DNA-PKcs. Our studies suggested that in addition to the
interaction with various pro-apoptotic proteins, the association with certain mitochondrial proteins such
as DNA-PKcs and prohibitins might augment the survival function of BCL-xL in virus infected cells.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Apoptosis is a physiological process of cell death in multi-
cellular organisms that eliminates unwanted and diseased cells
without inducing general inﬂammation and affecting the neigh-
boring cells. This process is regulated by the BCL-2 family anti-
apoptotic and pro-apoptotic proteins. In mammalian cells, several
anti-apoptotic and pro-apoptotic proteins have been identiﬁed
(reviewed in (Lomonosova and Chinnadurai, 2008)) and their
functions have been delineated. The cellular BCL-2 family anti-
apoptotic proteins include BCL-2, BCL-xL, MCL-1, BCL-w and A1/
BFL-1 (Reviewed by (Youle and Strasser, 2008)). These proteins are
characterized by the presence of four conserved domains desig-
nated BH (BCL-2 Homology) 1–4 and a C-terminal trans-mem-
brane (TM) domain. Most viral BCL-2 family anti-apoptosis
proteins also exhibit a similar domain structure while certain viral
proteins such as adenovirus E1B-19K possess more divergent
structures (reviewed by (Cuconati and White, 2002)). The BCL-2
family pro-apoptotic proteins include a class of multi-domain
proteins such as BAX and BAK which contain BH1-3 domains
and the TM domain. The second class of proteins known as the
BH3-only proteins such as BIK, BIM, BID and BAD, contain only the
BH3 domain with or without the TM domain. The BCL-2 family
anti-apoptosis proteins are predominantly localized in the outer
mitochondrial membrane (Youle and Strasser, 2008) while certain
proteins such as E1B-19K have been shown to localize in the
endoplasmic reticulum and nuclear envelope regions (White et al.,
1984). Research over the past decade by a number of research
groups has resulted in a consensus model for the regulation of
apoptosis by BCL-2 family members. Various apoptotic stimuli
have been shown to transcriptionally or post-transcriptionally
activate the expression of speciﬁc BH3-only proteins in stimuli-
speciﬁc manners. The BH3-only proteins serve as the effectors of
apoptosis by activating the multi-domain pro-apoptotic proteins
BAX and BAK to form oligomeric complexes on the outer mito-
chondrial membrane resulting in membrane permeablization, and
the exit of cytochrome c leading to caspase-dependent cell death.
Although, the precise modes of action of different BH3-only
molecules are not still fully resolved, some (e.g., BIM) have been
reported to bind with both the multi-domain pro-apoptotic and
anti-apoptotic proteins while other apoptotic proteins (e.g., BAD,
BIK) bind predominantly to anti-apoptotic proteins and activate
BAX and BAK indirectly. It is unclear whether the interaction of
anti-apoptotic proteins with both BH3-only and the multi-domain
pro-apoptotic proteins is required to suppress apoptosis. Further,
the functional signiﬁcance of the interaction between the anti-
apoptotic proteins and the pro-apoptotic molecules at the cognate
location (e.g., mitochondrial membrane) in the promotion of cell
survival has not been determined.
Most of the proteins that interact with BCL-2, BCL-xL and
related anti-apoptosis proteins such as E1B-19K were originally
identiﬁed under non-physiological conditions such as two-hybrid
analysis (e.g., BIK (Boyd et al., 1995), BAD (Yang et al., 1995) and
HRK (Inohara et al., 1997)) or in vitro screening of cDNA expression
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libraries (e.g., BIM (O'Connor et al., 1998) and BID (Wang et al.,
1996)). Other BCL-2 family pro-apoptotic proteins such as BAK
were identiﬁed on the basis of amino acid sequence similarities to
the BH domains (Chittenden et al., 1995; Kiefer et al., 1995).
Attempts to identify protein factors that are physiologically asso-
ciated with BCL-2 family anti-apoptosis proteins by the use of
proteomic approaches have been difﬁcult due to their strong
association with intra-cytosolic membranes. In this communica-
tion we have exploited a strategy developed by Nibert and cow-
orkers that employed a speciﬁc domain of mammalian ortho-
reovirus (MRV) mNS protein to target chimeric proteins to cytosolic
factory-like inclusion bodies to visualize protein–protein interac-
tions (Miller et al., 2007, 2010). We used this approach to target
BCL-xL and E1B-19K to cytosolic factory-like structures (FLS) and
to study interactions with anti-apoptotic proteins and to identify
novel interacting proteins.
Results
In this study, we targeted the cellular anti-apoptotic protein
BCL-xL and the viral anti-apoptosis protein adenovirus E1B-19K
into FLS; away from their normal localization sites and analyzed
their cell survival functions and interaction with cellular proteins.
We used a region of 252 aa (471–721) of the mNS FLS (Broering et
al., 2005) to target BCL-xL and E1B-19K into cytoplasmic inclusion
bodies. We constructed three adenovirus mutants that contain
deletion of the E1B region and substitution of sequences coding for
GFP-mNS, BCLxL-GFP-mNS or 19K-GFP-mNS (Fig. 1(A)). All three
chimeric proteins contained 3X Flag tag, TEV peptide (Tobacco
etch virus protease cleavage site) and a ST peptide (Strep-III Tag,
(Yeliseev et al., 2007)). All chimeric constructs were expressed
under the control of CMV immediate early promoter.
Subcellular localization of FLS-tagged BCL-xL and E1B-19K
First, we examined the expression of fusion proteins from the
lysates of virus infected A549 cells by western blot analysis (Fig. 1
(B)). All three virus mutants expressed chimeric proteins of the
expected sizes. Additionally, we also observed certain low mole-
cular weight proteins in cells infected with different mutants. We
believe that the low molecular proteins which might represent
potential degradation products of the full length chimeric proteins
and might not interfere with the proteome analysis of associated
proteins as well as microscopic GFP-based visualization of inter-
acting proteins due to the unique structural conﬁguration of the
chimeric protein (Fig. 1(A)). We then examined the localization of
the chimeric proteins by GFP ﬂuorescence and immunoﬂuores-
cence analyses (Fig. 1(C)). As seen in the ﬁgure, FLS-tagged GFP,
BCLxL-GFP and E1B19K-GFP appeared in distinct granular struc-
tures in the cytoplasm while wt GFP (indicated as Ad-GFP in Fig. 1
(C)) ﬂuorescence was distributed throughout the cells. The loca-
lization of FLS-tagged E1B19K-GFP was closer to the nuclear
envelope region while BCLxL-GFP granules were more dispersed
in the cytoplasm. Immunoﬂuorescence analysis of wt BCL-xL (Ad-
BCLxL in Fig. 1(C)) and wt E1B-19K (hAd5 wt in Fig. 1(C)) expressed
from the adenovirus vectors localized in the nuclear envelope,
mitochondria and endoplasmic reticulum regions (bottom two
panels of Fig. 1(C)). The expression patterns of the untagged BCL-
xL and E1B-19K were distinct from the granular localization of
FLS-tagged proteins. The predicted sizes of the cleavage products
of the chimeric proteins (Fig. 1(B)) suggested potential common
proteolytic cleavage site(s) at the N-terminal region of the mNS
domain raising the possibility that some fractions of the chimeric
proteins may lack mNS sequences. However, the GFP ﬂuorescence
indicated distinct granular localization suggesting the cleavage
products lacking mNS sequences might not localize at speciﬁc sites
or might be labile.
Since native BCL-xL (Vander Heiden et al., 1997) and E1B-19K
(White et al., 1984) have been known to predominantly localize in
the mitochondria and ER, respectively, we then analyzed the
potential localization of the FLS-tagged versions in these cytosolic
organelles by staining the infected cells with mito-Tracker (Fig. 2
(A)) or ER-Tracker (Fig. 2(B)). The majority of the FLS-tagged fusion
protein-containing granules were excluded by from the mito-
tracker and ER-tracker staining regions. Among the three FLS-
tagged proteins, a minor fraction of E1B19K-GFP appeared to loc-
alize in the mito-tracker staining regions. These results suggest
that the orthoreovirus mNS domain targets the fusion proteins to
the cytoplasmic inclusion bodies, away from the canonical mito-
chondrial and ER localization sites, overcoming the functions of
the membrane targeting domains of BCL-xL and E1B-19K.
Cell survival activity of FLS-tagged BCL-xL and E1B-19K chimeric
proteins
It is well established that adenovirus mutants defective in the
anti-apoptosis protein E1B-19K induce apoptosis of virus infected
cells and produce large plaques on target cell monolayers due to
excessive cell death (Subramanian et al., 1984). We have shown
that substitution of the viral E1B-19K protein coding sequences
with the sequences coding for the cellular anti-apoptosis proteins
BCL-2 or BCL-xL in the viral genome efﬁciently suppressed apo-
ptosis (Subramanian et al., 2007; Tarodi et al., 1993). Here, we
tested the apoptotic activity of the recombinant viruses that exp-
ressed FLS-tagged GFP (i.e., in the absence of E1B, ΔE1B) or FLS-
tagged E1B19K-GFP or FLS-tagged BCLxL-GFP. The infected cells
were analyzed for the activation of caspase by western blot
analysis of PARP (Fig. 3(A)). As expected, in cells infected with
different MOI of the FLS-tagged GFP (ΔE1B) recombinant there
was readily detectable PARP cleavage compared to cells infected
with viruses that expressed chimeric BCL-xL or E1B-19K. We
determined the extent of cell death induced by different viruses,
with or without etoposide treatment (additional apoptotic stimu-
lus). We found that infection with the FLS-tagged GFP recombi-
nant virus induced signiﬁcant amount of cell death. Addition of
sub-optimal concentration (20 mM) of etoposide did not induce
any cell death in mock-infected cells. However, etoposide treat-
ment of cells infected with the FLS-tagged GFP virus enhanced cell
death compared to infection with FLS-tagged GFP virus alone.
Infection with the recombinants expressing chimeric BCL-xL or
E1B-19K signiﬁcantly suppressed cell death in the presence as well
as absence of etoposide compared to the virus that expressed
chimeric GFP (Fig. 3(B)). We also evaluated the plaque morphol-
ogies on cell monolayers (Fig. 3(C)). The virus that expressed the
chimeric GFP formed more large plaques than the viruses that
expressed BCLxL-GFP or E1B19K-GFP consistent with the cell
death assay. Semi-quantitative measurement of the plaque sizes
(using Image J software) was in agreement of the visual evaluation.
Taken together, these results suggest that FLS-tagged BCLxL-GFP
and E1B19K-GFP chimeric proteins suppressed the cell death
induced by adenovirus (ΔE1B) infection as well as by co-treat-
ment with etoposide. However, we acknowledge the possibility
that some of the cell survival activity might be contributed by the
proteolytic products of the chimeric proteins that may correspond
to untagged versions.
Proteomic analysis of BCL-xL associated proteins
The cellular anti-apoptotic proteins BCL-xL and BCL-2 as well as
the viral homolog, E1B-19K have been reported to interact with
several pro-apoptotic proteins. Many of these interactions were
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identiﬁed under a variety of non-physiological contexts. The
strong association of these anti-apoptotic molecules with cytosolic
membranes (i.e., mitochondrial outer membrane and nuclear
envelope/ER) prevented unbiased proteomic analysis of BCL-2
family proteins. Our present studies showed that FLS-tagged
BCL-xL and E1B-19K suppressed apoptosis despite being predo-
minantly concentrated in factory-like inclusion bodies. We ratio-
nalized that the concentration of the FLS-tagged BCL-xL and E1B-
19K along with the pro-apoptotic interacting proteins within the
non-membrane inclusion bodies might be exploited for the isola-
tion and unbiased proteomic analysis of the respective protein
complexes. We prepared protein extracts (Material and methods)
from HeLa cells infected with recombinant adenoviruses expres-
sing FLS-tagged GFP, BCLxL-GFP or E1B19K-GFP. The protein
complexes were isolated by a single step afﬁnity chromatography
using Flag Ab beads, and analyzed by LC–MS mass spectrometry.
The list of proteins present in BCLxL-GFP and E1B19K-GFP pro-
teomes are shown in Table 1 and none of proteins in the list were
present in control GFP proteome. The BCL-xL proteome contained
proteins such as the ATP synthase, DNA-PKcs, heat shock protein
(HSP) 27, prohibitin-2 and pro-apoptotic proteins BID and BIK.
Among these proteins, ATP synthase and HSP 27 were present in
the E1B-19K proteome also. ATP synthase has previously been
reported to interact with BCL-xL to enhance the metabolic efﬁ-
ciency of neurons (Alavian et al., 2011). The DNA-PK activity has
been linked to the regulation of apoptosis during DNA double
strand break repair (Callen et al., 2009). However, interaction
between these proteins was not reported. We also identiﬁed the
mitochondrial protein prohibitin 2 in the BCL-xL proteome.
Although the functional consequence of the interaction of prohi-
bitin with BCL-xL is not known, such interaction was reported by
others (Vento et al., 2010).
The FLS-tagged BCL-xL and E1B-19K proteomes were validated by
western blot analysis (Fig. 4). The interaction of DNA-PKcs, ATP
synthase, prohibitin 2 and its heterodimeric partner prohibitin 1 as
well the as pro-apoptotic molecules BAX, BAK, BID, BIK and BIMwere
readily detectable in the BCL-xL proteome while the interactions of
only BAK and modest levels of BIM were detected in the E1B-19K
proteome. It is possible that our protocol for the protein complex
preparation may not extract sufﬁcient amount of E1B-19K complex.
The negative results obtained with E1B-19K might also be due to
lower levels of chimeric 19K protein expression. The interaction of
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Fig. 1. (A) Schematic diagram of the E1 region of recombinant hAdv5. The recombinant viruses express the indicated chimeric proteins in the E1B region under the control of
CMV-IE promoter. GFP, BCLxL-GFP and E1B19K-GFP are tagged at the N-terminus with Flag, TEV and ST tags and at the C-terminus with the orthoreovirus mNS domain.
(B) Expression of chimeric proteins by recombinant viruses. The proteins expressed in infected A549 cells were analyzed by western blotting using Flag antibody and
visualized with western blotting detection system. (C) Localization of GFP fusion proteins into cytoplasmic inclusion bodies. The infected cells were stained with BCL-xL and
E1B-19K antibodies. The immunoﬂuorescence and GFP ﬂuorescence were viewed in several ﬁelds and a single representative ﬁeld in each category was photographed using
a confocal microscope.
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HSP 27 could not be detected with both proteomes. It is not certain
whether the available panel of HSP 27 Abs is sensitive enough to
detect such interactions. We also note that we have observed robust
interaction between the BH3-only molecule BIK and E1B-19K in
hAdv5-infected cells (Subramanian et al., 2007). However, we were
unable to detect such interaction between FLS-tagged E1B-19K-GFP
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Fig. 2. Mitochondrial and ER localization of chimeric proteins. Cells were infected with various viruses and after 24 h of infection, mito-Tracker (A) or ER-Tracker (B) were
added to the cells in medium and Hank's buffer respectively for 30 min, ﬁxed and analyzed using a confocal microscope.
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chimeric protein and BIK, suggesting that the potential subcellular
localization may play a role in determining BIK/E1B-19K interaction.
Interaction with multi-domain pro-apoptotic proteins
It is believed that in normal cells the expression of pro-
apoptotic proteins and anti-apoptotic proteins are in a balanced
state to maintain the homeostasis of the organism. In addition,
these proteins are localized in their speciﬁc cellular locations such
as the mitochondrial outer membrane and/or the ER to mediate
their activities. The subcellular localization studies with FLS-
targeted BCLxL-GFP and E1B19K-GFP (Fig. 1(C) and Fig. 2) suggest
that the chimeric anti-apoptosis proteins were able to suppress
virus-induced apoptosis (Fig. 3) despite their non-canonical loca-
lization in distinct factory-like cytoplasmic granules. Since it is
believed that the anti-apoptosis proteins exert their activity by
neutralizing the cell death activities of pro-apoptotic molecules it
was of interest to visualize such interactions in the cytosolic
factory-like granules. We determined co-localization of endogen-
ous multi-domain pro-apoptotic proteins BAK and BAX (Fig. 5) as
well as BH3-only pro-apoptotic proteins (Fig. 6) with the chimeric
FLS-tagged BCLxL-GFP and E1B19K-GFP. Immunoﬂuorescence ana-
lysis of BAK in mock infected cells (Fig. 5, bottom panels) and in
cells infected with the FLS-GFP virus (Fig. 5, top panels) suggested
BAK localization in the nuclear envelope/ER/mitochondrial regions
that are distinct from the punctate GFP localization sites, suggest-
ing no detectable co-localization of BAK and GFP (Fig. 5, top
panels). In cells infected with BCLxL-GFP or E1B19K-GFP viruses,
BAK was co-localized with the chimeric anti-apoptosis proteins in
the cytoplasmic inclusion bodies (Fig. 5, middle two panels).
Similarly the pro-apoptotic protein BAX was detected throughout
the cytoplasmic region (Fig. 5(B), bottom most panel). In virus-
infected cells, BAX was relocalized in a more punctate fashion
(Fig. 5, top three panels), consistent with the reports that BAX was
activated by conformational changes and targeted to mitochondria
in cells experiencing apoptotic burden (Hsu et al., 1997; Hsu and
Youle, 1997). In cells expressing FLS-tagged BCLxL-GFP (Fig. 5,
third panel from top), most of BCLxL-GFP was localized in the
factory-like granules and was co-localized with BAX, as seen in the
case of BAK. In contrast, only a small fraction of E1B19K-GFP
appeared to contain BAX (Fig. 5(B), second panel from top). As
expected, some amount of BAK and BAX might be complexed with
endogenous BCL-xL/BCL-2 with high afﬁnity and might not be
available for interaction with the ectopically expressed chimeric
anti-apoptosis proteins. Such endogenous interactions may limit
quantitative co-localization with the chimeric anti-apoptosis
proteins.
Interaction with BH3-only pro-apoptotic proteins
We then used the orthoreovirus mNS platform to determine the
interaction of BCL-xL and E1B-19K with the BH3-only molecules
BID, BIM and BIK (Fig. 6). The localization of BID and BIM (Fig. 6
(A) and (B)) was very interesting. In cells infected with chimeric
BCLxL-GFP, BID and BIM were exclusively localized in the cyto-
plasmic inclusion bodies indicating that BCLxL-GFP interacted
with most BID and BIM proteins in these granules (Fig. 6(A) and
(B)). In cells that expressed the chimeric E1B19K-GFP protein, BIM
was colocalized in the cytosolic granules to some extent while BID
was excluded. We also observed some amount of BID was
colocalized with the GFP protein in the inclusion bodies. We do
not understand the signiﬁcance of this apparent non-speciﬁc
localization. BIK was colocalized with BCLxL-GFP to some extent
in the inclusion bodies and not at detectable levels with E1B19K-
GFP (Fig. 6(C)). These immunoﬂuorescence and GFP ﬂuorescence
analyses (Figs. 5 and 6) suggest that the interaction of BAX and
BAK as well as select BH3-only proteins within the factory-like
granules may contribute to the anti-apoptotic activities of the
chimeric BCL-xL and E1B-19K proteins.
Effect of DNA-PK and prohibitins in regulating the activity of BCL-xL
Among the various proteins present in the BCL-xL proteome,
we chose to determine the roles of DNA-PK and prohibitins in the
regulation of the apoptotic activity during hAdv5 infection and
Fig. 3. Suppression of apoptosis by chimeric BCL-xL and E1B-19K proteins localized
at non-canonical sites. (A) A549 cells were infected with the recombinant viruses at
different MOI and 24 h post infection cells were lysed and analyzed by western
blotting to determine the extent of PARP cleavage (top panel). The western blot
with the Flag Ab (lower panel) shows the levels of expression of different
recombinant proteins. (B) Effects on apoptosis. A549 cells were infected with
different viruses (50 pfu/cell) and cell viability was determined by trypan blue
using a BIORAD cell counter. The experiment was repeated three times and the
statistical differences were assessed using two-tail student t-test with 95%
conﬁdent. P-value was determined by comparing mock vs Ad-FLS-GFP, mockþetop
vs Ad-FLS-GFPþetop, Ad-FLS-GFP vs Ad-FLS-BCLxL-GFP and Ad-FLS-E1B19K-GFP
and Ad-FLS-GFPþetop vs Ad-FLS-BCLxL-GFPþetop and Ad-FLS-E1B19K-GFPþetop.
Signiﬁcance was accepted at a value of *po0.05, **po0.01 and ***po0.005.
(C) Plaque morphology of recombinant viruses. A549 cells were infected with the
recombinant viruses and assayed for plaque formation (Subramanian et al., 2007).
The diameters of 24–50 plaques were measured using ImageJ and the relative
diameter (Rel.Dia.) is shown at the bottom of each dish.
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etoposide treatment (Fig. 7). Although the activity of DNA-
activated protein kinase (DNA-PK) has been implicated in mod-
ulating apoptosis during DNA repair catastrophe (Callen et al.,
2009), the interaction of DNA-PKcs with BCL-xL has not been
reported earlier. Prohibitin 2 has been previously reported to
interact with BCL-xL (Vento et al., 2010) and inhibit apoptosis
induced by staurosporine and ceramide (Chowdhury et al., 2011,
2007). We depleted DNA-PKcs and prohibitins 1 and 2 in human
A549 cells using lentiviral shRNA vectors (Fig. 7(A)). In cells
depleted for DNA-PKcs, there was readily detectable reduction in
the level of DNA-PKcs (Fig. 7(A) left panel). Prohibitins exist as a
hetero-dimer of prohibitin 1 and 2 (Berger and Yaffe, 1998). When
prohibitin 2 was depleted, the level of prohibitin 1 was also
reduced. Similarly, when prohibitin1 was depleted, the level of
prohibitin 2 was reduced. Therefore, we used A549 cells that were
acutely depleted for prohibitin 2 for cell death assays. In control
A549 cells infected with the recombinant virus expressing GFP (i.e,
in the absence of E1B, ΔE1B), there was signiﬁcant cell death. The
extent of cell death was further enhanced by treatment with
etoposide (Fig. 7(B), left panel). As expected, in cells infected with
recombinant viruses that express BCLxL-GFP or E1B19K-GFP chi-
meric proteins the levels of cell death were signiﬁcantly reduced.
Although cells depleted for DNA-PKcs (DNA-PK↓) or prohibitin
(prohibitin↓) exhibited comparable cell death proﬁles (Fig. 7
center and right panels), cells infected with the BCL-xL-GFP
recombinant virus exhibited enhanced levels of cell death (com-
pared to the control A549 cells). Although we were unable to see
the interaction of prohibitins with E1B-19K, the cell death assays
in prohibitin-depleted cells showed that there was a detectable
effect on the cell survival activity of E1B-19K indicating that
prohibitins may play a role at the early phase of apoptosis. Our
results are in agreement with a previous report that showed that
BCL-xL was unable to prevent staurosporine induced cell death
when prohibitin 2 was depleted (Chowdhury et al., 2013). Taken
together our results suggest that DNA-PK and prohibitins may
augment the survival function of BCL-xL in cells treated with the
anti-cancer agent etoposide without signiﬁcant effect on virus-
induced apoptosis. In addition, DNA-PK and prohibitins did not
appear to be required for the survival function of E1B-19K in the
Table 1
(A) List of proteins present in BCL-xL (A) and E1B-19K proteome (B) against control GFP. HeLa cells (30150 mm2 dishes) were infected with 5 pfu/cell of BCLxL-GFP,
E1B19K-GFP or the control GFP virus for 24 h and the cells were lysed using a buffer containing 20 mM Hepes pH 7.6, 100 mM potassium acetate, 200 mM sodium chloride,
2 mM magnesium chloride, 0.1% Tween 20, 0.25% Triton X, 2.5 mM PMSF and protease inhibitor cocktail. The lysates were immunoprecipitated with the Flag Ab, digested
with trypsin and subjected to LC–MS/MS analysis. The samples were analyzed using Mascot (Matrix Science,.London, UK; version 2.5.1) for the database search. Scaffold
(version Scaffold_4.4.1.1, Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide and protein identiﬁcations. Peptide identiﬁcations were accepted if
they could be established at greater than 80.0% probability by the Scaffold Local FDR algorithm. Protein identiﬁcations were accepted if they could be established at greater
than 99.0% probability and contained at least 2 identiﬁed peptides. * – We note the presence of adenovirus E1B-19K in the BCLxL proteome. Since virus stocks were prepared
in 293 cells, there is a possibility that the Ad-FLS-BclxL-GFP virus may contain a small fraction of Ad5 wt virus due to recombination in 293 cells that might express low levels
of E1B-19K in cells infected with BCLxL recombinant virus.
Table 1A: List of proteins present in Bcl-xL proteome
Name of protein Accession number Molecular weight
Bcl-2-like protein 1-like isoform 5 GI:109092453 26 kDa
Protein kinase, DNA-activated, catalytic polypeptide GI:119607088 469 kDa
Adenovirus E1B-19Kn GI:9626162 21 kDa
ATP synthase, Hþ transporting mitochondrial F1 complex, alpha subunit 1 GI:127798841 60 kDa
Heat shock protein 27 GI:15928919 21 kDa
Adenovirus 5 late protein 100K GI:56160547 90 kDa
Prohibitin-2 GI:114051223 33 kDa
Pro-apoptotic protein Bid, chain A GI:159163783 22 kDa
Similar to STIP1 homology and U-box containing protein 1 isoform 3 GI:114660202 33 kDa
Solute carrier family 25 GI:158455003 33 kDa
D-3-phosphoglycerate dehydrogenase isoform 3 GI:109014683 56 kDa
Bcl-2 interacting killer GI:30584757 18 kDa
Thyroid receptor-interacting protein 13 isoform 1 GI:11321607 49 kDa
Table 1B: List of proteins present in E1B-19K proteome
Name of protein Accession number Molecular weight
ATP synthase, Hþ transporting mitochondrial F1 complex, alpha subunit 1 GI:127798841 60 kDa
Adenovirus E1B-19K GI:9626162 21 kDa
Heat shock protein 27 GI:15928919 21 kDa
Fig. 4. Interaction of BCL-xL and E1B-19K fusion proteins with cellular proteins.
A549 cells were infected with various viruses (50 pfu/cell). Twenty four hours after
infection proteins were immunoprecipitated, resolved by 4–12% gradient PAGE
cells and analyzed by immune blotting.
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Fig. 5. Interaction of BAK (A) and BAX (B) with BCL-xL and E1B-19K fusion proteins. Cells were plated on coverslips and infected with the recombinant viruses (50 pfu/cell)
and 24 h after infection, ﬁxed and immune-stained using various antibodies as mentioned in Fig.1(C).
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Fig. 6. Localization of BH3-only pro-apoptotic proteins with BCL-xL and E1B-19K fusion proteins. (A) Localization of BID. (B) Localization of BIM. (C) Localization of BIK. The
549 cells were infected and analyzed as in Fig. 5.
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presence of etoposide and adenovirus infection together while it
enhanced E1B-19K function during virus infection alone.
Discussion
Miller et al. (2007, 2010) have developed a system to visualize
protein–protein interactions within the cell by targeting the
protein complex to discrete cytosolic factory-like inclusion bodies
using a domain of the mNS protein of orthoreovirus. Here, we have
utilized this system to target the cellular and viral anti-apoptosis
proteins BCL-xL and E1B-19K to the cytosolic factory-like struc-
tures. The chimeric proteins appeared to retain, at least, some of
their anti-apoptotic activity despite their non-canonical localiza-
tion in the discrete cytosolic bodies away from their normal
membrane locations in the outer mitochondrial membrane and
the ER/nuclear envelope regions.
We investigated the FLS-tagged chimeric BCLxL-GFP and E1B19K-
GFP proteins to analyze their interaction with several known pro-
apoptotic proteins. We found co-localization of BCLxL-GFP with the
multi-domain pro-apoptotic proteins BAX and BAK, as well as with
certain BH3-only proteins. These results suggested that the anti-
apoptotic activities of BCL-xL and E1B-19K proteins might be linked
to the interaction of, at least, a fraction of BAX and BAK as well as the
BH3-only proteins such as BIM and BID despite their interaction away
from their normal localization sites. Our results strengthen the view
that the BCL-2 family anti-apoptosis proteins may exert their cell
survival function by interacting with pro-apoptotic proteins. It is
possible that the interaction between the pro-apoptotic proteins and
anti-apoptotic proteins may be dynamic process in the FLS as rep-
orted earlier (Miller et al., 2007). Such interactions may moderate the
activities of the pro-apopototic proteins in a dynamic fashion in cells
infected with the recombinant viruses. Our FLS-aided visualization
studies also revealed the BCL-xL-GFP chimeric protein was found to
complex only with a fraction of the multi-domain pro-apoptotic
proteins. Although the reason for non-quantitative sequestration is
unknown, it is possible that only a fraction of BAX and BAK might be
‘activated’ to apoptotic competence which is targeted by the ectopi-
cally expressed anti-apoptotic molecule. An alternate explanation
may include that a fraction of the activated BAX/BAK molecules
might be sequestered by the endogenous BCL-2/BCL-xL proteins
rendering them unavailable for interaction with exogenous anti-
apoptosis proteins. In contrast to the pattern of BAX and BAK
interaction, BCLxL-GFP interacted with the BH3-only molecules BIM
and BID more avidly (Fig. 6(A) and (B)), suggesting that sequestration
of the BH3-only molecules which function as the effectors of
apoptosis signaling (Lomonosova and Chinnadurai, 2008) may con-
tribute to the anti-apoptotic activity of BCL-xL.
In general, the expression of E1B19K-GFP resulted in more
pronounced anti-apoptotic activity (Fig. 3). However, E1B19K-GFP
exhibited a narrow interaction pattern with the pro-apoptotic
proteins than BCLxL-GFP. E1B19K-GFP appeared to exhibit a pre-
ference for interaction with BAK than BAX. Similar results were also
observed by the western blot analysis (Fig. 4). Among the BH3-only
proteins, only BIM was found interact with E1B19K-GFP (Fig. 6(B)).
While BIK was found to be a major target for E1B-19K in cells
infected hAdv5 wt (Subramanian et al., 2007), there was no detect-
able interaction between FLS-tagged E1B19K-GFP and BIK. Taken
together the present study suggests that sequestration of a combina-
tion of the multi-domain and BH3-only pro-apoptotic proteins by
BCL-2 family anti-apoptosis proteins may lead to suppression of
apoptosis.
In our present study, we have also exploited the FLS-mediated
targeting of interacting protein complexes for unbiased proteomic
analysis of BCL-xL. Although our analysis is not extensive, we were
able to identify a novel association of DNA-PKcs with BCL-xL and
determine its effect on the anti-apoptotic activity of BCL-xL. The
identiﬁcation of several previously known BCL-xL-interacting pro-
teins such as ATP synthase, prohibitins and BCL-2 family pro-
apoptotic proteins validated the utility of the approach. However,
we note the limited utility of the approach for the identiﬁcation of
E1B-19K-associated proteins. It appears that additional improve-
ments may be needed to extract the E1B-19K-associated protein
complex from the FLS-containing structures. We show that BCL-xL, in
addition to sequestering BCL-2 family pro-apoptotic proteins also
recruit proteins such as DNA-PKcs and prohibitins to modulate virus-
induced apoptosis. This protein targeting system may be useful to
analyze the proteomes of other membrane associated BCL-2 family
proteins.
Materials and methods
Cells and viruses
Human A549, HeLa and 293 cells were grown in Dulbecco
modiﬁed Eagle medium (DMEM) containing 10% fetal bovine serum.
For the construction of recombinant adenovirus mutants TEV (TEV,
tobacco etch virus protease cleavage site) and ST (Strep-III Tag, 20)
sequences were ﬁrst PCR ampliﬁed using a synthetic oligonucleotide
and cloned at the 50 multiple cloning site of p3XFlagCMV7.1 vector
Fig. 7. Role of DNA-PK and prohibitins on the anti-apoptosis activities of BCL-xL
and E1B-19K. (A) Depletion of DNA-PK and prohibitins. A549 cells were infected
with lentiviral vectors (pLKO-puro) that express shRNAs targeted against DNA-
PKcs, prohobitin 1 and prohibitin 2 and selected with puromycin. (B) Effect on BCL-
xL activity. The acutely depleted cells were pooled and infected with the
recombinant viruses (50 pfu/cell) and the cell death assay was performed as
outlined in Fig. 2(B) in the presence and absence of etoposide. The experiment
was repeated three times and the statistical differences were assessed as in Fig. 3.
P-value was determined by comparing the 3 cell lines in the presence and absence
of etoposide. Signiﬁcance was accepted at values of **po0.01 and ***po0.005.
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(Sigma). The sequences coding for GFP—orthoreovirus mNS fusion
protein was then PCR ampliﬁed from pEGFP-C1-M3 (471–721,
(Broering et al., 2005)) and cloned at the 30 multiple cloning site.
The sequences coding for BCL-xL or E1B-19K were cloned into the
resulting vector between mNS and GFP sequences. The sequences
containing chimeric constructs of BCL-xL, E1B-19K or the control
(without BCL-xL or E1B-19K) were digested with SnaB I and BamH I
to release the fusion cassette and cloned into hAdv transfer vector,
pLendE1ACMV (Subramanian et al., 2007). The resultant plasmids
were cotransfected into 293 cells along with a hAdv genomic plasmid
pacAd5 9.2–100 to generate recombinant viruses. The recombin-
ant viruses Ad5ΔE1BFTEVSTGFPmNS (Ad-FLS-GFP), Ad5ΔE1BFTEVS-
TBclxLGFPmNS (Ad-FLS-BCLxL-GFP) and Ad5ΔE1BFTEVST19KGFPmNS
(Ad-FLS-E1B19K-GFP) were screened for protein expression, ampli-
ﬁed and puriﬁed by banding in CsCl density gradients and titrated
(Subramanian et al., 2007).
Cell death and plaque assays
A549 cells were infected with 50 PFU/cell of various viruses
and after one hr adsorption at 37 1C the mediumwas removed and
replaced with 2.5 ml of DMEM containing 10% FBS along with or
without 20 mM etoposide. After 36 h of post infection, the cells
were released by treatment with trypsin, stained with trypan blue
and counted in a BIORAD cell counter. The plaque assay was
carried out using A549 cells as reported earlier (Subramanian
et al., 2007).
Fluorescence analysis
Cells on coverslips were infected with 50 PFU/cell of hAdv5
mutants and the cells were ﬁxed at 24 h post infection. The ﬁxed
cells were immuno-stained with Abs speciﬁc to BCL-xL (Santa
Cruz), E1B19K (gift from M. Green), BAX (Upstate), BAK (Upstate),
BIK (Santa Cruz), BID (Santa Cruz) and BIM (Cell Signaling). Mito-
Tracker (Molecular probes) and ER-Tracker (Molecular probes)
were added to the cells in medium and Hank's buffer, respectively
at 24 h of post infection and the cells were ﬁxed at 30 min later.
The immunoﬂuorescence of stained cells and the ﬂuorescence
(GFP, mito-Tracker and ER-Tracker) of ﬁxed cells were analyzed by
confocal microscopy.
Proteomic analysis
HeLa cells (30150 mm2 dishes) were infected with 5 PFU/cell
of Ad-FLS-BCLxL-GFP, Ad-FLS-E1B19K-GFP or the control Ad-FLS-
GFP viruses for 24 h and the cells were lysed using a buffer
containing 20 mM Hepes pH 7.6, potassium acetate: 110 mM,
sodium chloride: 200 mM, magnesium chloride: 2 mM, Tween
20: 0.1%, Triton X: 0.25%, PMSF: 2.5 mM and protease inhibitor
cocktail. The lysates were spun for 30 min and the clear super-
natants were incubated for 30 min at 4 1C with agarose beads. The
agarose beads and the lysates were spun for 10 min and the
supernatants were rotated with agarose beads conjugated with
the Flag antibody for 1 h at 4 1C. The beads with protein complexes
were collected, washed 4 times with the lysis buffer and subjected
to trypsin digestion and LC–MS mass spectrometric analysis
(Danforth Plant Research Center, St. Louis).
Western blot analysis
Cells were infected with various viruses and cells were lysed at
24 h post-infection and protein complexes were isolated using anti-
Flag Ab coated agarose beads. The proteins bound to the beads were
washed 4 times and suspended in 40 ml sample buffer. The lysates
and immunoprecipitated samples were separated by 4–12% gradient
gels, transferred to nitrocellulose membrane and incubated at 4 1C
overnight with the following antibodies; anti-Flag (Sigma), anti-BIK,
anti-prohibitin 1 and 2 and anti-actin (Santa Cruz), anti-DNA-PKcs
and anti-ATP synthase (Protein Tech), anti-BAK and anti-BAX
(Upstate), anti-BIM, anti-BID and anti-PARP (BD Pharmingen). The
blots were washed and incubated with the corresponding secondary
antibodies conjugated with HRP (Santa Cruz) for 30 min. The blots
were then washed and the protein bands were visualized with
western blotting detection system (Roche) according to the manu-
facturer's speciﬁcations. The quantitation of cleaved PARP was carried
out using BIO-RAD CHEMI DOC XRS system bymeasuring the relative
intensities of the cleaved products.
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